Avidity Biosciences Inc (NASDAQ: RNA): Stock Forecast For 2025 Still Looks Weak With A -94.4% Decline
In the last trading session, 1.23 million shares of the Avidity Biosciences Inc (NASDAQ:RNA) were traded, and its beta was 0.97. Most recently the company’s